Den Hertog, Heleen M, Worp, H Bart, Algra, Ale, Kappelle, L Jaap, Van Gijn, Jan, ...
Abstract Background The Paracetamol (Acetaminophen) In Stroke (PAIS) study is a phase III multicenter, double blind, randomized, placebo-controlled clinical trial of high-dose acetaminophen in...
Hofmeijer, Jeannette, Amelink, G Johan, Algra, Ale, Van Gijn, Jan, Macleod, Malcolm R, Kappelle, L Jaap, ...
Abstract Background Patients with a hemispheric infarct and massive space-occupying brain oedema have a poor prognosis. Despite maximal conservative treatment, the case fatality rate may be as high...
Van Breda, Eric J, Van Der Worp, H Bart, Algra, Ale, Kappelle, L Jaap, Van Gijn, Jan, ...
Abstract Background In patients with acute stroke, increased body temperature is associated with large lesion volumes, high case fatality, and poor functional outcome. A 1°C increase in body...
Is clopidogrel superior to aspirin in secondary prevention of vascular disease? (2000)
Abstract The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel...
Hofmeijer, Jeannette, Amelink, G Johan, Algra, Ale, Van Gijn, Jan, Macleod, Malcolm R, Kappelle, L Jaap, ...
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus...
Hofmeijer, Jeannette, Amelink, G Johan, Algra, Ale, Van Gijn, Jan, Macleod, Malcolm R, Kappelle, L Jaap, ...
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus...